Signaling Pathways - CDK1/CyclinB - eIF4E/eIF3G interaction - Farnesoid X receptors (FXRs) - P-glycoprotein (P-gp)
清除全部
-
B4888 Obeticholic Acid2 Citation中文名: 奥贝胆酸Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂 -
B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂 -
B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: 竞争性的eIF4E/eIF4G相互作用抑制剂。 -
B1528 XL335Target: Farnesoid X receptors (FXRs)Summary: FXR激动剂 -
A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb（P糖蛋白）抑制剂 -
A8463 Lithocholic Acid中文名: 石胆酸Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)Summary: 维生素D受体PXR和FXR的激活剂 -
A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂 -
A3859 Tariquidar methanesulfonate, hydrate中文名: 他立喹达二甲磺酸盐六水合物Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂 -
A3384 Elacridar中文名: 依克立达Target: P-glycoprotein (P-gp)Summary: BCRP抑制剂 -
A8208 Tariquidar2 Citation中文名: 他立喹达Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂